Publications by authors named "Islam Baiev"

Claim this Profile
C
Changes in alpha-fetoprotein across the systemic therapy continuum in advanced hepatocellular carcinoma-a real-world, multicenter study.
Michael Li, Lindsay M Hannan, Lipika Goyal, Andrea G Bocobo, Anna L Parks, Islam Baiev

Ther Adv Med Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer.
Joy X Jarnagin, Anurag Saraf, Islam Baiev, Gary Chi, Emily E van Seventer

JAMA Netw Open· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma.
Leontios Pappas, Islam Baiev, Stephanie Reyes, Andrea Grace Bocobo, Apurva Jain

JCO Precis Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma.
Kristen Spencer, Leontios Pappas, Islam Baiev, Jordan Maurer, Andrea Grace Bocobo

J Natl Cancer Inst· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy.
Anuradha Budhu, Erica C Pehrsson, Aiwu He, Lipika Goyal, Robin Kate Kelley, Islam Baiev

Cell Rep Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Clinicopathologic Characteristics of Hypercalcemia in Patients With Cholangiocarcinoma.
Eirini Konstantinidou, Jordan R Maurer, Stephanie L Reyes, Islam Baiev, Jennifer R Stanton

JAMA Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined PD-1, BRAF and MEK inhibition in BRAF colorectal cancer: a phase 2 trial.
Jun Tian, Jonathan H Chen, Sherry X Chao, Karin Pelka, Marios Giannakis, Islam Baiev

Nat Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGFR mRNA Expression in Cholangiocarcinoma and Its Correlation with FGFR2 Fusion Status and Immune Signatures.
Vishwajith Sridharan, Azfar Neyaz, Abhijit Chogule, Islam Baiev, Stephanie Reyes

Clin Cancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion-Positive Cholangiocarcinoma.
Qibiao Wu, Yuanli Zhen, Lei Shi, Phuong Vu, Patricia Greninger, Islam Baiev

Cancer Discov· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer.
Aparna R Parikh, Emily E Van Seventer, Giulia Siravegna, Anna V Hartwig, Ariel Jaimovich, Islam Baiev

Clin Cancer Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Acquired Resistance to KRAS Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS-MAPK Reactivation.
Noritaka Tanaka, Jessica J Lin, Chendi Li, Meagan B Ryan, Junbing Zhang, Islam Baiev

Cancer Discov· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-free DNA captures tumor heterogeneity and driver alterations in rapid autopsies with pre-treated metastatic cancer.
Bernard Pereira, Christopher T Chen, Lipika Goyal, Charlotte Walmsley, Christopher J Pinto, Islam Baiev

Nat Commun· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma.
Lipika Goyal, Lei Shi, Leah Y Liu, Ferran Fece de la Cruz, Jochen K Lennerz, Islam Baiev

Cancer Discov· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis